Pyridostigmine
Anticholinesterases
- Drug class
- Anticholinesterases
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 8
Overview
Pyridostigmine is an active pharmaceutical ingredient in the Anticholinesterases group (N07AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | December 23, 2025 |
| GB United Kingdom | MHRA | 4 | November 10, 2025 |
USUnited States· FDA
4 products
Uses
INDICATIONS AND USAGE
Pyridostigmine Bromide Tablets USP are useful in the treatment of myasthenia gravis.
How to take
GBUnited Kingdom· MHRA
4 products
Uses
Myasthenia gravis, paralytic ileus and post-operative urinary retention.
How to take
Drug interactions
Known interactions involving Pyridostigmine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 0a114d99-e50b-49… · revised August 4, 2025 [PDF]
- [2]MHRA (UK) · PL136210081 · revised February 14, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.